IDEAYA Biosciences, Inc. (IDYA)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$158.8M
Cash & Equivalents
$75.2M
Quarterly Burn Rate
6 mo
Est. Cash Runway
$2,573M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT07277413 A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors PHASE1 Recruiting 260

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for IDYA.

SEC EDGAR Filings

All SEC filings for IDEAYA Biosciences, Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.